Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 4/2009

01-10-2009 | Conference Paper

Management of breast cancer: from standardization to personalization

Author: Hideo Inaji

Published in: Breast Cancer | Issue 4/2009

Login to get access

Excerpt

It was an honor and a privilege to serve as President of the 16th Annual Meeting of the Japanese Breast Cancer Society (JBCS), held on 26–27 September 2008 in Osaka. First, I would like to express my sincere appreciation to all the participants and all the members of the organizing committee whose dedication made this event such a success. …
Literature
1.
2.
Inaji H. Management of breast cancer—from standard to tailored. Jpn J Breast Cancer. 2009;24:173–80 (in Japanese with English abstract).
3.
The Japanese Breast Cancer Society: Breast Cancer 15 (Supplement 1) 2008.
Metadata
Title
Management of breast cancer: from standardization to personalization
Author
Hideo Inaji
Publication date
01-10-2009
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2009
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-009-0133-9

Other articles of this Issue 4/2009

Breast Cancer 4/2009 Go to the issue

Acknowledgment

Acknowledgment to reviewers 2009

Conference Paper

Algorithm for in vitro diagnostic multivariate index assay

Conference Paper

Clinicopathological characteristics of triple-negative breast cancers

Conference Paper

Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction

Conference Paper

Breast cancer risk assessment for possible tailored screening for Japanese women

Original Article

A cluster of microcalcifications: women with high risk for breast cancer versus other women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits